Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004126073 | SCV003597795 | uncertain significance | not specified | 2024-07-16 | criteria provided, single submitter | clinical testing | The c.46A>G (p.T16A) alteration is located in exon 3 (coding exon 1) of the RPP38 gene. This alteration results from a A to G substitution at nucleotide position 46, causing the threonine (T) at amino acid position 16 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |